Search

everythinglearnresearchcommunity

for

Search:↓

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Doxorubicin causes heart damage, so early detection and monitoring are important during chemotherapy.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

A new medical syndrome may include skin changes, hair loss, sweating issues, bone malformations, leg swelling, and low cortisol.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

Finasteride significantly increases scalp hair and prevents hair loss in young and middle-aged men.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Treatments for acute leukaemia lead to high remission rates, but relapses occur, requiring ongoing advancements in care.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Direct-to-consumer telemedicine in Australia needs formal evaluation for safety and quality.

High ferritin levels might be linked to chronic hair loss.

Ritlecitinib is safe and may effectively treat alopecia areata.

Long-term TPN in children can cause zinc deficiency, leading to health issues.

Patients and oncologists prioritize survival benefits, while payers focus on treatment costs.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

Teriflunomide effectively reduces relapse rates and disease progression in multiple sclerosis but is not safe for use during pregnancy.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.